Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?

被引：2
作者：
Brunetti, Natale Daniele [1 ]
De Gennaro, Luisa [2 ]
Di Biase, Matteo [3 ]
Caldarola, Pasquale [2 ]
机构：
[1] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[2] San Paolo Hosp, Cardiol Dept, Bari, Italy
[3] Santa Maria Hosp, GVM Care & Res, Bari, Italy
来源：
IJC HEART & VASCULATURE | 2019年 / 24卷
关键词：
Coronary artery disease; Peripheral artery disease; Rivaroxaban; Ticagrelor; Clinical management; TICAGRELOR; PREVENTION; RATIONALE; ASPIRIN; EVENTS; DESIGN;
D O I：
10.1016/j.ijcha.2019.100401
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk
    Nakamura, Masato
    Kadota, Kazushige
    Nakao, Koichi
    Nakagawa, Yoshihisa
    Shite, Junya
    Yokoi, Hiroyoshi
    Kozuma, Ken
    Tanabe, Kengo
    Akasaka, Takashi
    Shinke, Toshiro
    Ueno, Takafumi
    Hirayama, Atsushi
    Uemura, Shiro
    Harada, Atsushi
    Kuroda, Takeshi
    Takita, Atsushi
    Iijima, Raisuke
    Murakami, Yoshitaka
    Saito, Shigeru
    CIRCULATION JOURNAL, 2021, 85 (06) : 785 - +
  • [22] Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
    Chi-Juei Jeng
    Yi-Ting Hsieh
    Cheng-Li Lin
    I-Jong Wang
    BMC Ophthalmology, 22
  • [23] Endoscopic sinus surgery in patients receiving anticoagulant or antiplatelet therapy
    Sargi, Zoukaa
    Casiano, Roy
    AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (03): : 335 - 338
  • [24] Add-on Antiplatelet Effects of Eicosapentaenoic Acid With Tailored Dose Setting in Patients on Dual Antiplatelet Therapy
    Hosogoe, Naoyoshi
    Ishikawa, Shuichi
    Yokoyama, Naoyuki
    Kozuma, Ken
    Isshiki, Takaaki
    INTERNATIONAL HEART JOURNAL, 2017, 58 (04) : 481 - 485
  • [25] Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
    Byung Joon Park
    Linle Hou
    Andrew Galmer
    Hillary Johnston-Cox
    Current Treatment Options in Cardiovascular Medicine, 2023, 25 : 379 - 390
  • [26] Safety of percutaneous nephrolithotomy in patients on chronic anticoagulant or antiplatelet therapy
    Fernandez-Baltar, C.
    Perez-Fentes, D.
    Sanchez-Garcia, J. F.
    Garcia-Freire, C.
    UROLITHIASIS, 2018, 46 (06) : 581 - 585
  • [27] Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery
    Grzybowski, Andrzej
    Ascaso, Francisco J.
    Kupidura-Majewski, Konrad
    Packer, Mark
    CURRENT OPINION IN OPHTHALMOLOGY, 2015, 26 (01) : 28 - 33
  • [28] Lesion Complexity and Prolonged Antiplatelet Therapy The Missing Variable to Complete the Puzzle
    Lozano, Inigo
    Rondan, Juan
    Vegas, Jose M.
    Segovia, Eduardo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (10) : 1186 - 1187
  • [29] Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
    Yan, Xiaodi
    Wang, Baoyan
    Xia, Peng
    Lan, Chen
    Wang, Qian
    Ge, Weihong
    Zhou, Yujie
    Jiang, Chenxiao
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [30] Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
    Berkowitz, Scott D.
    Bauersachs, Rupert M.
    Szarek, Michael
    Nehler, Mark R.
    Debus, E. Sebastian
    Patel, Manesh R.
    Anand, Sonia S.
    Capell, Warren H.
    Hess, Connie N.
    Hsia, Judy
    Leeper, Nicholas J.
    Brasil, David
    Matyas, Lajos
    Diaz, Rafael
    Brodmann, Marianne
    Muehlhofer, Eva
    Haskell, Lloyd P.
    Bonaca, Marc P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (05) : 1193 - 1205
12345